SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
January 4, 2022
Patent Extends Protection for its Novel Compounds and Methods Already granted in Australia and Japan TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), marks... Read more
SciSparc Awarded Three Patents For Its Novel Compounds and Methods
September 7, 2021
Ryan Allway September 7th, 2021 TEL AVIV, Israel, Sept. 7, 2021 /PRNewswire/ — SciSparc Ltd. (OTC Pink: SPRCF), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company”), today announced it has been awarded two patents from the Australian Patent... Read more
IONIC Brands to Produce CBD Vape Products in Japan, Its First International Licensing Agreement
May 17, 2021
Ryan Allway May 17th, 2021 TACOMA, WA / ACCESSWIRE / May 17, 2021 / IONIC BRANDS CORP. (CSE:IONC)(OTC PINK:IONKF)(FRA:1B3) (“IONIC BRANDS” or the “Company”) is a regional manufacturer of innovative cannabis consumables and concentrate extract products, is pleased to announce that together with REPS JAPAN Co. Ltd., (“REPS”), the parties... Read more
